Press Releases

06.09.2010
Circadian granted key strategic VEGF-D patent in USA for diagnostic applications
11.08.2010
Two Licentia inventors, Professor Kari Alitalo and Dosent Mikko Niemi, receive prestigious Anders Jahre's Awards for Medical Research 2010
14.05.2009
Longterm Licentia Partner, Professor Kari Alitalo, Wins Prestigious Award for Biomedical Research
27.11.2008
Licentia’s thesis award to Henna Tyynismaa
16.07.2008
Circadian Technologies Ltd (Melbourne, Australia, ASX: CIR) will buy the remaining third of its subsidiary Vegenics as part of its strategy to move from a biotech incubator to a biologics drug development company.
11.06.2008
The DNA Repair Company, a Boston-based cancer treatment company that emphasizes customized care, has been granted exclusive licensing rights by Licentia for a breast cancer diagnostic test developed at Helsinki University Central Hospital.
11.06.2008
2008 Millennium Technology Prize Awarded to Professor Robert Langer for Intelligent Drug Delivery
29.02.2008
Kari Paukkeri named new CEO of Licentia
25.02.2008
Intellectual property developed at the University of Helsinki part of $500 million licensing agreement
14.01.2008
Lymphatix was sold to Ark Therapeutics
07.12.2007
Licentian väitöskirjapalkinto Terhi Kärpäselle
01.08.2007
Markku Jalkanen Licentiaan
03.05.2006
Uusi yritys syöpälääkekehitykseen
26.04.2006
Marjo Uotila siirtyi Tekesistä Licentiaan
01.04.2006
Licentia hallinnoi kansallisesti koko Suomen LIKSA -rahoitusta
19.01.2006
Licentia muuttaa uusiin toimitiloihin